Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients

Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

(2015) Stian Knappskog et al.   Oncotarget

Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism

(2014) Radosław Polański et al.   CANCER LETTERS

Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells

(2013) David J Panka et al.   Molecular Cancer

p53/mdm2 Feedback Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma

(2013) Francesca Fornari et al.   MOLECULAR CANCER RESEARCH

Mdm2 SNP309 G-Variant Is Associated with Invasive Growth of Human Urinary Bladder Cancer

(2013) Florian Hitzenbichler et al.   PATHOBIOLOGY

Correlation ofTP53andMDM2genotypes with response to therapy in sarcoma

(2012) Hege O. Ohnstad et al.   CANCER

p53 and MDM2 in renal cell carcinoma

(2010) Aidan P. Noon et al.   CANCER

Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis

(2009) Konstantinos P. Economopoulos et al.   BREAST CANCER RESEARCH AND TREATMENT

Suppression of Hypoxia-Inducible Factor 2  Restores p53 Activity via Hdm2 and Reverses Chemoresistance of Renal Carcinoma Cells

(2009) A. M. Roberts et al.   CANCER RESEARCH

MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians

(2009) Xian-Hua Gui et al.   EUROPEAN JOURNAL OF CANCER

The genetics of the p53 pathway, apoptosis and cancer therapy

(2008) Alexei Vazquez et al.   NATURE REVIEWS DRUG DISCOVERY

MDM2SNP309 Does Not Associate with Elevated MDM2 Protein Expression or Breast Cancer Risk

(2008) Daniel Krekac et al.   ONCOLOGY

Genetic polymorphisms ofMDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk

(2007) Geoffrey Liu et al.   INTERNATIONAL JOURNAL OF CANCER